ArticleExploratory research in clinical and social pharmacy2025
The impact of comprehensive pharmaceutical care on medication safety in gynecologic oncology chemotherapy patients.
Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the impact of our hospital's full-course pharmacy service on the safety and rationality of medication in patients with gynecologic malignancies undergoing chemotherapy. Methods: A retrospective cohort analysis was conducted on patients who underwent chemotherapy in the Gynecologic Oncology Ward at Peking University First Hospital between September 2022 and September 2024. Patients were divided into a control group, who received routine pharmaceutical care based on clinical medication prescription review, and the intervention group, who received comprehensive pharmaceutical care throughout their treatment. This included prescription review, medication education, drug consultation, and adverse reaction management. The incidence of severe adverse reactions, the appropriateness of leukopoietic treatment and monitoring, and the rate of unplanned hospital admissions were compared between the two groups. Results: The intervention group demonstrated a significantly lower incidence of severe nausea (6.1 % vs 11.4 %, Conclusion: Comprehensive pharmaceutical care has a positive impact on medication safety for gynecologic oncology patients, significantly reducing the incidence of severe adverse reactions and the rate of unplanned hospital admissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.